23 May 2013
Keywords: cytokinetics, abandons, ispinesib, ph, ii, usa-based, small-molecule
Article | 03 April 2006
USA-based small-molecule drugmaker Cytokinetics says that its cancer drug ispinesib did not meet the necessary criteria to proceed to the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 April 2006
© 2013 thepharmaletter.com